<SEC-DOCUMENT>0001994702-23-000001-index.html : 20231107
<SEC-HEADER>0001994702-23-000001.hdr.sgml : 20231107
<ACCEPTANCE-DATETIME>20231106195342
ACCESSION NUMBER:		0001994702-23-000001
CONFORMED SUBMISSION TYPE:	D
PUBLIC DOCUMENT COUNT:		1
ITEM INFORMATION:		<ITEMS>06b
FILED AS OF DATE:		20231107
DATE AS OF CHANGE:		20231106
EFFECTIVENESS DATE:		20231107

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Kyverna Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001994702
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				831365441
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		D
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	021-496597
		FILM NUMBER:		231381223

	BUSINESS ADDRESS:	
		STREET 1:		5980 HORTON STREET
		STREET 2:		SUITE 550
		CITY:			EMERYVILLE
		STATE:			CA
		ZIP:			94608
		BUSINESS PHONE:		5106268331

	MAIL ADDRESS:	
		STREET 1:		5980 HORTON STREET
		STREET 2:		SUITE 550
		CITY:			EMERYVILLE
		STATE:			CA
		ZIP:			94608
</SEC-HEADER>
<DOCUMENT>
<TYPE>D
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
Document 1 - file: primary_doc.html

Document 1 - RAW XML: primary_doc.xml

</DOCUMENT>
</SEC-DOCUMENT>